P-cadherin antibodies

Details for Australian Patent Application No. 2006238930 (hide)

Owner Pfizer Inc.

Inventors Joy, William Dean; Griggs, David William; Head, Richard David; Mazzarella, Richard Allen; Minter, Ralph Raymond; Boyle, Melanie; Vanarsdale, Todd Lee; Moffat, Mark Allen; Casperson, Gerald Fries; Bourner, Maureen Jeri; Thiele, Barrett Richard; Bauer, Christopher Todd

Agent Spruson & Ferguson

Pub. Number AU-B-2006238930

PCT Pub. Number WO2006/114704

Priority 60/675,311 26.04.05 US

Filing date 13 April 2006

Wipo publication date 2 November 2006

Acceptance publication date 23 December 2010

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

1 November 2007 PCT application entered the National Phase

  PCT publication WO2006/114704 Priority application(s): WO2006/114704

23 December 2010 Application Accepted

  Published as AU-B-2006238930

21 April 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006238933-Amino acid derivatives

2006238925-Ventilator circuit and method for the use thereof